{
    "id": 26875,
    "fullName": "PIK3CA K966E",
    "impact": "missense",
    "proteinEffect": "gain of function - predicted",
    "geneVariantDescriptions": [
        {
            "description": "PIK3CA K966E lies within the PI3K/PI4K domain of the Pik3ca protein (UniProt.org). K966E results in activation of Pik3ca signaling as indicated by increased phosphorylation of Akt and Mapk3/Mapk1 (Erk1/2), and confers resistance to Erbitux (cetuximab) in culture (PMID: 28424201) and therefore, is predicted to result in a gain of Pik3ca protein function.",
            "references": [
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 9728,
                    "pubMedId": 28424201,
                    "title": "PIK3CA Mutations Contribute to Acquired Cetuximab Resistance in Patients with Metastatic Colorectal Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28424201"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 5290,
        "geneSymbol": "PIK3CA",
        "terms": [
            "PIK3CA",
            "CLAPO",
            "CLOVE",
            "CWS5",
            "MCAP",
            "MCM",
            "MCMTC",
            "p110-alpha",
            "PI3K",
            "PI3K-alpha"
        ]
    },
    "variant": "K966E",
    "createDate": "08/16/2017",
    "updateDate": "09/14/2018",
    "referenceTranscriptCoordinates": {
        "id": 171942,
        "transcript": "NM_006218",
        "gDna": "chr3:g.179230336A>G",
        "cDna": "c.2896A>G",
        "protein": "p.K966E",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 11720,
            "approvalStatus": "Clinical Study - Cohort",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical study, PIK3CA K966E was identified as a potential mechanism for acquired Erbitux (cetuximab) resistance in a colorectal cancer patient, which is supported by cell culture studies demonstrating resistance to Erbitux (cetuximab) and Fluorouracil combination treatment in colorectal cancer cells overexpressing PIK3CA K966E (PMID: 28424201).",
            "molecularProfile": {
                "id": 28199,
                "profileName": "PIK3CA K966E"
            },
            "therapy": {
                "id": 2000,
                "therapyName": "Cetuximab + Fluorouracil",
                "synonyms": null
            },
            "indication": {
                "id": 9256,
                "name": "colorectal cancer",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 9728,
                    "pubMedId": 28424201,
                    "title": "PIK3CA Mutations Contribute to Acquired Cetuximab Resistance in Patients with Metastatic Colorectal Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28424201"
                }
            ],
            "ampCapAscoEvidenceLevel": "C",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 28199,
            "profileName": "PIK3CA K966E",
            "profileTreatmentApproaches": [
                {
                    "id": 17534,
                    "name": "Akt Inhibitor (Pan)",
                    "profileName": "PIK3CA K966E"
                },
                {
                    "id": 17531,
                    "name": "Akt2 Inhibitor",
                    "profileName": "PIK3CA K966E"
                },
                {
                    "id": 17533,
                    "name": "mTORC2 Inhibitor",
                    "profileName": "PIK3CA K966E"
                },
                {
                    "id": 17530,
                    "name": "mTORC1 Inhibitor",
                    "profileName": "PIK3CA K966E"
                },
                {
                    "id": 17528,
                    "name": "mTOR Inhibitor",
                    "profileName": "PIK3CA K966E"
                },
                {
                    "id": 17532,
                    "name": "Akt1 Inhibitor",
                    "profileName": "PIK3CA K966E"
                },
                {
                    "id": 17527,
                    "name": "PI3K Inhibitor (Pan)",
                    "profileName": "PIK3CA K966E"
                },
                {
                    "id": 17529,
                    "name": "PIK3CA inhibitor",
                    "profileName": "PIK3CA K966E"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 171942,
            "transcript": "NM_006218",
            "gDna": "chr3:g.179230336A>G",
            "cDna": "c.2896A>G",
            "protein": "p.K966E",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 171941,
            "transcript": "XM_006713658",
            "gDna": "chr3:g.179230336A>G",
            "cDna": "c.2896A>G",
            "protein": "p.K966E",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 171943,
            "transcript": "XM_011512894",
            "gDna": "chr3:g.179230336A>G",
            "cDna": "c.2896A>G",
            "protein": "p.K966E",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}